vs
ACORN ENERGY, INC.(ACFN)与FATE THERAPEUTICS INC(FATE)财务数据对比。点击上方公司名可切换其他公司
ACORN ENERGY, INC.的季度营收约是FATE THERAPEUTICS INC的1.7倍($2.4M vs $1.4M),FATE THERAPEUTICS INC同比增速更快(-26.4% vs -32.6%),过去两年ACORN ENERGY, INC.的营收复合增速更高(5.6% vs -15.7%)
Acorn Energy是一家在纳斯达克上市的综合企业,主营业务为电力能源与能源安全领域投资。公司最早由乔治·摩根斯特恩于1984年创立,原名Decision Systems, Inc.,由莱德劳证券协助完成上市,后历经多次更名,2006年约翰·摩尔出任首席执行官后最终定为现名。
因西斯治疗是1990年成立、总部位于亚利桑那州钱德勒的美国特色制药企业,核心产品Subsys是芬太尼的舌下含服液体制剂。芬太尼是一种见效极快的强效阿片类药物,用于缓解癌症患者爆发性疼痛,在美国,用于该适应症的芬太尼处方通常要求已有记录证明保守疗法无效。
ACFN vs FATE — 直观对比
营收规模更大
ACFN
是对方的1.7倍
$1.4M
营收增速更快
FATE
高出6.2%
-32.6%
两年增速更快
ACFN
近两年复合增速
-15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.4M | $1.4M |
| 净利润 | $1.1M | — |
| 毛利率 | 80.1% | — |
| 营业利润率 | 11.7% | — |
| 净利率 | 45.2% | — |
| 营收同比 | -32.6% | -26.4% |
| 净利润同比 | -79.5% | 37.9% |
| 每股收益(稀释后) | $0.42 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACFN
FATE
| Q4 25 | $2.4M | $1.4M | ||
| Q3 25 | $2.5M | $1.7M | ||
| Q2 25 | $3.5M | $1.9M | ||
| Q1 25 | $3.1M | $1.6M | ||
| Q4 24 | $3.5M | $1.9M | ||
| Q3 24 | $3.0M | $3.1M | ||
| Q2 24 | $2.3M | $6.8M | ||
| Q1 24 | $2.1M | $1.9M |
净利润
ACFN
FATE
| Q4 25 | $1.1M | — | ||
| Q3 25 | $252.0K | $-32.3M | ||
| Q2 25 | $720.0K | $-34.1M | ||
| Q1 25 | $464.0K | $-37.6M | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $725.0K | $-47.7M | ||
| Q2 24 | $271.0K | $-38.4M | ||
| Q1 24 | $65.0K | $-48.0M |
毛利率
ACFN
FATE
| Q4 25 | 80.1% | — | ||
| Q3 25 | 78.5% | — | ||
| Q2 25 | 74.9% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 72.4% | — | ||
| Q3 24 | 71.7% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 74.6% | — |
营业利润率
ACFN
FATE
| Q4 25 | 11.7% | — | ||
| Q3 25 | 6.4% | -1995.1% | ||
| Q2 25 | 26.9% | -1938.5% | ||
| Q1 25 | 19.5% | -2534.1% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | 24.8% | -1703.9% | ||
| Q2 24 | 11.3% | -665.7% | ||
| Q1 24 | 3.7% | -2652.9% |
净利率
ACFN
FATE
| Q4 25 | 45.2% | — | ||
| Q3 25 | 10.2% | -1852.4% | ||
| Q2 25 | 20.4% | -1786.6% | ||
| Q1 25 | 15.0% | -2309.5% | ||
| Q4 24 | 148.3% | — | ||
| Q3 24 | 23.8% | -1551.0% | ||
| Q2 24 | 11.9% | -567.4% | ||
| Q1 24 | 3.0% | -2493.7% |
每股收益(稀释后)
ACFN
FATE
| Q4 25 | $0.42 | — | ||
| Q3 25 | $0.10 | $-0.27 | ||
| Q2 25 | $0.28 | $-0.29 | ||
| Q1 25 | $0.19 | $-0.32 | ||
| Q4 24 | $2.08 | — | ||
| Q3 24 | $0.29 | $-0.40 | ||
| Q2 24 | $0.11 | $-0.33 | ||
| Q1 24 | $0.03 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5M | $203.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.3M | $207.2M |
| 总资产 | $13.3M | $318.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ACFN
FATE
| Q4 25 | $4.5M | $203.7M | ||
| Q3 25 | $4.2M | $215.4M | ||
| Q2 25 | $3.3M | $222.8M | ||
| Q1 25 | $2.6M | $240.4M | ||
| Q4 24 | $2.3M | $279.1M | ||
| Q3 24 | $2.2M | $296.9M | ||
| Q2 24 | $1.5M | $304.9M | ||
| Q1 24 | $1.4M | $121.3M |
股东权益
ACFN
FATE
| Q4 25 | $8.3M | $207.2M | ||
| Q3 25 | $7.2M | $234.1M | ||
| Q2 25 | $6.9M | $261.4M | ||
| Q1 25 | $6.1M | $288.4M | ||
| Q4 24 | $5.5M | $318.7M | ||
| Q3 24 | $288.0K | $362.3M | ||
| Q2 24 | $-451.0K | $397.0M | ||
| Q1 24 | $-733.0K | $426.1M |
总资产
ACFN
FATE
| Q4 25 | $13.3M | $318.9M | ||
| Q3 25 | $12.4M | $343.7M | ||
| Q2 25 | $12.5M | $371.6M | ||
| Q1 25 | $11.1M | $398.7M | ||
| Q4 24 | $10.6M | $440.7M | ||
| Q3 24 | $5.4M | $495.0M | ||
| Q2 24 | $4.8M | $528.8M | ||
| Q1 24 | $4.9M | $569.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $295.0K | $-106.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-112.0M |
| 自由现金流率自由现金流/营收 | — | -8183.9% |
| 资本支出强度资本支出/营收 | — | 434.8% |
| 现金转化率经营现金流/净利润 | 0.27× | — |
| 过去12个月自由现金流最近4个季度 | — | $-199.6M |
8季度趋势,按日历期对齐
经营现金流
ACFN
FATE
| Q4 25 | $295.0K | $-106.1M | ||
| Q3 25 | $895.0K | $-24.4M | ||
| Q2 25 | $629.0K | $-24.6M | ||
| Q1 25 | $271.0K | $-33.8M | ||
| Q4 24 | $166.0K | $-122.9M | ||
| Q3 24 | $698.0K | $-29.4M | ||
| Q2 24 | $84.0K | $-32.3M | ||
| Q1 24 | $-43.0K | $-33.4M |
自由现金流
ACFN
FATE
| Q4 25 | — | $-112.0M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | — | $-25.9M | ||
| Q1 25 | — | $-35.0M | ||
| Q4 24 | — | $-123.6M | ||
| Q3 24 | — | $-29.9M | ||
| Q2 24 | — | $-32.4M | ||
| Q1 24 | — | $-33.4M |
自由现金流率
ACFN
FATE
| Q4 25 | — | -8183.9% | ||
| Q3 25 | — | -1526.5% | ||
| Q2 25 | — | -1360.7% | ||
| Q1 25 | — | -2148.9% | ||
| Q4 24 | — | -6645.4% | ||
| Q3 24 | — | -973.1% | ||
| Q2 24 | — | -477.8% | ||
| Q1 24 | — | -1736.9% |
资本支出强度
ACFN
FATE
| Q4 25 | — | 434.8% | ||
| Q3 25 | — | 126.5% | ||
| Q2 25 | — | 71.4% | ||
| Q1 25 | — | 73.4% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 16.1% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 4.5% |
现金转化率
ACFN
FATE
| Q4 25 | 0.27× | — | ||
| Q3 25 | 3.55× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.96× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | -0.66× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACFN
| PG | $2.2M | 94% |
| Other | $143.0K | 6% |
FATE
暂无分部数据